Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population

References

• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2163-96
   PubMed Web of Science ®Google Scholar
• Natoli J, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010;30:599-609
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache Rep 2014;18:385
   PubMed Web of Science ®Google Scholar
• Eadie MJ. The pathogenesis of migraine - 17th to early 20th century understandings. J Clin Neurosci 2005;124:383-8
   Google Scholar
• Gasparini CF, Sutherland HG, Griffiths LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics 2013;14:300-15
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Charbit AR, Andreou AP, et al. Neurobiology of migraine. Neuroscience 2009;161(2):327-41
   PubMed Web of Science ®Google Scholar
• Cui Y, Kataoka Y, Watanabe Y. Role of cortical spreading depression in the pathophysiology of migraine. Neurosci Bull 2014;30(5):812-22
   PubMed Web of Science ®Google Scholar
• Welch KM, Brandes AW, Salerno L, et al. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006;46:197-9
   PubMed Web of Science ®Google Scholar
• Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007;27:843-6
   PubMed Web of Science ®Google Scholar
• Munno I, Marinaro M, Bassi A, et al. Immunological aspects in migraine: increased IL-10 plasma levels during attack. Headache 2001;41:764-7
   PubMed Web of Science ®Google Scholar
• Diener HC. CGRP as a new target in prevention and treatment of migraine. Lancet Neurol 2014;13(11):1065-7
   Google Scholar
• Carrera P, Stenirri S, Ferrari M, et al. Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull 2001;56(3-4):239-41
   Google Scholar
• Hoffmann J, Recober A. Migraine and triggers: post hoc ergo propter hoc? Curr Pain Headache Rep 2013;17(10):370
   PubMed Web of Science ®Google Scholar
• Sangiorgi S, Mochi M, Riva R, et al. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 1994;14:21-3
   PubMed Web of Science ®Google Scholar
• Shimomura T, Kowa H, Nakano T, et al. Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994;14:215-18
   PubMedGoogle Scholar
• Welch KM, Levine SR, D’Andrea G, et al. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989;39:538-41
   PubMed Web of Science ®Google Scholar
• Montagna P, Cortelli P, Barbiroli B, et al. Magnetic resonance spectroscopy studies in migraine. Cephalalgia 1994;14:184-93
   Google Scholar
• Barbiroli B, Montagna P, Cortelli P, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992;42:1209-14
   PubMed Web of Science ®Google Scholar
• Colombo B, Saraceno L, Comi G. Riboflavin and migraine: the bridge over troubled mitochondria. Neurol Sci 2014;35(Suppl 1):141-4
   PubMed Web of Science ®Google Scholar
• Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics 2012;287:837-44
   PubMed Web of Science ®Google Scholar
• Sparaco M, Feleppa M, Lipton RB, et al. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2006;26(4):361-72
   PubMedGoogle Scholar
• Schoenen J, Jacquy J, Lenaerts M. Effectiveness of highdose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology 1998;50:466-70
   PubMed Web of Science ®Google Scholar
• Di Lorenzo C, Pierelli F, Coppola G, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 2009;72:1588
   PubMed Web of Science ®Google Scholar
• Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005;25:593-7
   PubMed Web of Science ®Google Scholar
• Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors in migraine: the GEM population-based study. Neurology 2005;19:683-92
   Google Scholar
• Winsvold BS, Sandven I, Hagen K, et al. Migraine, headache and development of metabolic syndrome: an 11-year follow-up in the Nord-Trøndelag Health Study (HUNT). Pain 2013;154:1305-11
   Google Scholar
• Sacco S, Ripa P, Grassi D, et al. Peripheral vascular dysfunction in migraine: a review. J Headache Pain 2013;14:80
   PubMed Web of Science ®Google Scholar
• Buse DC, Manack A, Serrano D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010;81:428-32
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Migraine chronification. Curr Neurol Neurosci Rep 2011;11:139-48
   PubMed Web of Science ®Google Scholar
• Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep 2011;15(1):70-8
   PubMed Web of Science ®Google Scholar
• Ho E, Karimi Galougahi K, Liu CC, et al. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 2013;1:483-91
   PubMed Web of Science ®Google Scholar
• Hsieh HL, Yang CM. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int 2013;2013:484613
   PubMed Web of Science ®Google Scholar
• Bauer M, Gräbsch C, Schlink U, et al. LISAplus Study Group. Genetic association between obstructive bronchitis and enzymes of oxidative stress. Metabolism 2012;61:1771-9
   Google Scholar
• Palta P, Samuel LJ, Miller ERIII, et al. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 2014;76:12-19
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Aydin O, Yegin A, et al. Impaired oxidative balance and association of blood glucose, insulin and HOMA-IR index in migraine. Biochem Med 2011;21:145-51
   Web of Science ®Google Scholar
• Yilmaz N, Aydin O, Yegin A, et al. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 2011;44:832-7
   PubMed Web of Science ®Google Scholar
• Alp R, Selek S, Alp SI, et al. Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 2010;14:877-82
   PubMed Web of Science ®Google Scholar
• Bernecker C, Ragginer C, Fauler G, et al. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol 2011;18:1233-9
   PubMed Web of Science ®Google Scholar
• Gruber HJ, Bernecker C, Pailer S, et al. Hyperinsulinaemia in migraineurs is associated with nitric oxide stress. Cephalalgia 2010;30:593-8
   Google Scholar
• Gruber HJ, Bernecker C, Lechner A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia 2010;30:486-92
   PubMed Web of Science ®Google Scholar
• Vurucu S, Karaoglu A, Paksu MS, et al. Relationship between oxidative stress and chronic daily headache in children. Hum Exp Toxicol 2013;32:113-19
   PubMed Web of Science ®Google Scholar
• Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, et al. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 2007;27:1136-41
   PubMed Web of Science ®Google Scholar
• Giampaoli S, Chillemi G, Valeriani F, et al. The SNPs in the human genetic blueprint era. N Biotechnol 2013;30:475-84
   Google Scholar
• ICHD-2r Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004;24:9-160
   Google Scholar
• National Center for Biotechnology Information (NCBI) SNP database. Available from: www.ncbi.nlm.nih.gov/snp/
   Google Scholar
• Tests for deviation from Hardy-Weinberg equilibrium and tests for association. Available from: http://ihg.gsf.de/cgi-bin/hw/hwa1.pl
   Google Scholar
• SNPStats software. Available from: http://bioinfo.iconcologia.net/SNPstats
   Google Scholar
• Solé X, Guinó E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22:1928-9
   PubMed Web of Science ®Google Scholar
• Quanto software version 1.2.4. Available from: http://biostats.usc.edu/cgi-bin/DownloadQuanto.pl
   Google Scholar
• Mattsson P, Bjelfman C, Lundberg PO, et al. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine. Eur J Clin Invest 2000;30:367-71
   PubMed Web of Science ®Google Scholar
• Kusumi M, Ishizaki K, Kowa H, et al. Glutathione S-transferase polymorphisms: susceptibility to migraine without aura. Eur Neurol 2003;49:218-22
   PubMed Web of Science ®Google Scholar
• Yıldırım S, Akar S, Kuyucu M, et al. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Cell Biochem Funct 2011;29:549-54
   PubMed Web of Science ®Google Scholar
• Gonçalves FM, Luizon MR, Speciali JG, et al. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem 2012;370:183-9
   Google Scholar
• de O S Mansur T, Gonçalves FM, Martins-Oliveira A, et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem 2012;364:303-8
   Google Scholar
• Nadeem A, Siddiqui N, Alharbi NO, et al. Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into blood. Pulm Pharmacol Ther 2014;29(1):31-40
   PubMed Web of Science ®Google Scholar
• Mangge H, Becker K, Fuchs D, et al. Antioxidants, inflammation and cardiovascular disease. World J Cardiol 2014;6(6):462-77
   PubMedGoogle Scholar
• Eslami S, Sahebkar A. Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies. Curr Hypertens Rep 2014;16(6):432
   PubMed Web of Science ®Google Scholar
• Kodydková J, Vávrová L, Kocík M, et al. Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia Biol (Praha) 2014;60(4):153-67
   PubMed Web of Science ®Google Scholar
• Collins AR. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 2005;81(1 Suppl):261-7
   Google Scholar
• Palmieri B, Sblendorio V. Current status of measuring oxidative stress. Methods Mol Biol 2010;594:3-17
   Google Scholar
• Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventative. Cephalalgia 2002;22:137-41
   PubMed Web of Science ®Google Scholar
• Orr SL, Venkateswaran S. Nutraceuticals in the prophylaxis of pediatric migraine: evidence-based review and recommendations. Cephalalgia 2014;34(8):568-83
   PubMed Web of Science ®Google Scholar
• Marriage B, Clandinin MT, Glerum DM. Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc 2003;103:1029-38
   PubMed Web of Science ®Google Scholar
• Prousky J, Seely D. The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature. Nutr J 2005;4:3
   Google Scholar
• Boehnke C, Reuter U, Flach U, et al. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004;11:475-7
   PubMed Web of Science ®Google Scholar
• Bruijn J, Duivenvoorden H, Passchier J, et al. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia 2010;30(12):1426-34
   PubMed Web of Science ®Google Scholar
• Tarighat Esfanjani A, Mahdavi R, Ebrahimi Mameghani M, et al. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res 2012;150(1-3):42-8
   Google Scholar
• Slater SK, Nelson TD, Kabbouche MA, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011;31(8):897-905
   PubMed Web of Science ®Google Scholar
• Tana C, Tafuri E, Tana M, et al. New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain 2013;14:9
   PubMed Web of Science ®Google Scholar
• Lionetto L, Capi M, Vignaroli G, et al. Deciphering the task of N-acetyl aspartate in migraine. Expert Rev Neurother 2012;12:1057-9
   Web of Science ®Google Scholar
• Negro A, Rocchietti-March M, Fiorillo M, et al. Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci 2011;15:1401-20
   PubMed Web of Science ®Google Scholar
• Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 2011;12:593-601
   PubMed Web of Science ®Google Scholar
• Louter M, Fernandez-Morales J, de Vries B, et al. Candidate-gene association study searching for genetic factors involved in migraine chronification. Cephalalgia 2014. [Epub ahead of print]
   Google Scholar
• Gentile G, Borro M, Lala N, et al. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 2010;11(5):431-5
   PubMed Web of Science ®Google Scholar
• Terrazzino S, Sances G, Balsamo F, et al. Role of 2 common variants of 5HT2A gene in medication overuse headache. Headache 2010;50:1587-96
   Google Scholar
• Di Lorenzo C, Sances G, Di Lorenzo G, et al. The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett 2007;424:179-84
   Google Scholar
• Di Lorenzo C, Di Lorenzo G, Sances G, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 2009;10:349-55
   PubMedGoogle Scholar
• Lionetto L, Negro A, Palmisani S, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs 2012;17(3):393-406
   PubMed Web of Science ®Google Scholar
• Dodick DW, Turkel CC, DeGryse RE, et al. PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921-36
   PubMed Web of Science ®Google Scholar
• Aurora SK, Dodick DW, Turkel CC, et al. PREEMPT 1 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010;30:793-803
   PubMed Web of Science ®Google Scholar
• Dodick DW, Silberstein SD, Reed KL, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia 2014. [ Epub ahead of print]
   Google Scholar
• Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2011;31(3):271-85
   PubMed Web of Science ®Google Scholar
• Gentile G, Chiossi L, Lionetto L, et al. Pharmacogenetic insights into migraine treatment in children. Pharmacogenomics 2014;15(11):1539-50
   PubMed Web of Science ®Google Scholar
• Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6(9):733-43
   PubMed Web of Science ®Google Scholar
• Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61(3):154-66
   PubMed Web of Science ®Google Scholar
• Shimoda-Matsubayasgi S, Matumine H, Kobayashi T, et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 1996;22:6561-5
   Google Scholar
• Sutton A, Khoury H, Prip-Buus C, et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57
   PubMedGoogle Scholar
• Nadif R, Mintz M, Jedlicka A, et al. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005;39:1345-50
   PubMed Web of Science ®Google Scholar
• Atay AE, Akbas H, Tumer C, et al. The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes. Clin Nephrol 2014;81(2):105-11
   Google Scholar
• Mackness B, Mackness MI, Arrol S, et al. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998;423(1):57-60
   PubMed Web of Science ®Google Scholar
• Izzicupo P, Di Valerio V, D’ Amico MA, et al. NAD(P)H oxidase and pro-inflammatory response during maximal exercise: role of C242T polymorphism of the P22PHOX subunit. Int J Immunopathol Pharmacol 2010;23(1):203-11
   Google Scholar
• Vibhuti A, Arif E, Mishra A, et al. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD. Clin Chim Acta 2010;411(7-8):474-80
   Web of Science ®Google Scholar